News Release

Zogenix to Present at the Jefferies 2017 Global Healthcare Conference


EMERYVILLE, Calif., May 31, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today announced that Michael P. Smith, Executive Vice President, Chief Financial Officer & Treasurer and Secretary, will present a corporate overview at the Jefferies 2017 Global Healthcare Conference, taking place on June 6-9, 2017, in New York, NY.

Zogenix Presentation Details

Date:  Wednesday, June 7, 2017
Time:  2:00 pm Eastern Time / 11:00 am Pacific Time

The presentation will be webcast live and archived for 30 days on Zogenix's Investor Relations website at

About Zogenix
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.

For more information, visit

Investors: Andrew McDonald
Founding Partner, LifeSci Advisors LLC
646-597-6987 |

Primary Logo

Zogenix, Inc.